Mr Tim Dudderidge

MB ChB, MSc, FRCS (Urol)
GMC: 4505451
- Prostate MRI and image-fusion biopsies.
- Focal therapy: HIFU, cryotherapy, NanoKnife.
- Robotic prostatectomy and second opinions.
- Benign prostate enlargement and urinary symptoms.
- British Association of Urological Surgeons.
- BAUS Section of Oncology.
- Royal College of Surgeons of England.
- British Medical Association.
25
A UK leader in prostate cancer care
Tim is a Consultant Urological Surgeon and lead of prostate cancer surgical trials at University Hospital, Southampton. Tim specialises in prostate cancer and is one of a handful of clinicians combining an interest in imaging and precision diagnostics with skills in both focal therapy and robotic surgery for prostate cancer.
He received his Doctorate of Medicine in 1998, and more recently, a Research Doctorate, both from the University of Bristol. He trained in London and spent time undertaking research at University College London, gaining an MSc degree. He went through urological training at all the leading cancer centres including Kings College Hospital, University College Hospital, Imperial Healthcare and the Royal Marsden Hospital where he also worked as a consultant. Tim was awarded a Royal College of Surgeons Uro-Oncology Fellowship at Imperial in 2009 and subsequently was the UK’s First Robotic Surgery Fellow at Royal Marsden Hospital.
Hear what Mr Tim Dudderidge has to say about Focal Therapy
Professional profiles
- BAUS Member Profile: British Association of Urological Surgeons
- Top Doctors Profile: Top Doctors
- Patient Reviews: Doctify (5/5 stars from 42 reviews)
- Insurance Coverage: Bupa Finder
Research and publications
- Salvage Focal Therapy vs Radical Prostatectomy for Localized Radiorecurrent Prostate Cancer. JAMA Oncology. 2026. https://doi.org/10.1001/jamaoncol.2025.6448
- Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic Prostate Cancer: A Multi-institute 15-year Experience. European Urology. 2022. https://doi.org/10.1016/j.eururo.2022.01.005
- Regional Histopathology and Prostate MRI Positivity: A Secondary Analysis of the PROMIS Trial. Radiology. 2022. https://doi.org/10.1148/radiol.220762
- Evaluation of Outcomes Following Focal Ablative Therapy for Treatment of Localized Clinically Significant Prostate Cancer in Patients >70 Years: A Multi-institute, Multi-energy 15-Year Experience. Journal of Urology. 2023. https://doi.org/10.1097/JU.0000000000003443
- Focal Therapy Compared to Radical Prostatectomy for Non-metastatic Prostate Cancer: A Propensity Score-matched Study. Prostate Cancer and Prostatic Diseases. 2021. https://doi.org/10.1038/s41391-020-00315-y
- Prostate Specific Antigen Criteria to Diagnose Failure of Cancer Control Following Focal Therapy of Nonmetastatic Prostate Cancer Using High Intensity Focused Ultrasound. Journal of Urology. 2020. https://doi.org/10.1097/JU.0000000000000747
- Evaluation of Functional Outcomes After a Second Focal High-intensity Focused Ultrasonography (HIFU) Procedure in Men with Primary Localized, Non-metastatic Prostate Cancer: Results from the HIFU Evaluation and Assessment of Treatment (HEAT) Registry. BJU International. 2020. https://doi.org/10.1111/bju.15004
- Focal HIFU Therapy for Anterior Compared to Posterior Prostate Cancer Lesions. World Journal of Urology. 2020. https://doi.org/10.1007/s00345-020-03297-7
- A Prospective Prostate Cancer Screening Programme for Men with Pathogenic Variants in Mismatch Repair Genes (IMPACT): Initial Results from an International Prospective Study. Lancet Oncology. 2021. https://doi.org/10.1016/S1470-2045(21)00522-2
- Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study. European Urology. 2026. https://doi.org/10.1016/j.eururo.2026.01.031
Learn more about Focal Therapy and Prostate Cancer
Survey of Prostate Cancer Patients Reveals Severe Knowledge Gaps Among Men
How Accurate is a Urine test for Prostate Cancer – and can it replace PSA or MRI?
Is Testosterone Replacement Therapy Safe After Prostate Cancer Treatment?
Any questions?
If you’ve got any questions about your prostate cancer diagnosis or want to know more about HIFU or NanoKnife, don’t hesitate to get in touch with our friendly, knowledgeable team.
Contact the team
Subscribe to our newsletter
Get expert advice & the latest prostate cancer research - straight to your inbox.
